Impax Laboratories, Inc.

Volume 165 · 165 F.T.C. 1407

Citation: 165 F.T.C. 1407
Docket: 9373
Decision: 2018-01-19
Document type: interlocutory order
Case type: antitrust
Industry: pharmaceuticals
Outcome: other
Relief: other
Source: Original volume PDF
Original PDF: This decision as a PDF

Cite this decision

Impax Laboratories, Inc., 165 F.T.C. 1407 (2018). Consumer Law Library, https://consumerlawlibrary.org/decisions/v165-0026

Report an error in this record (decision id v165-0026)

Order status: unknown. Sunset may be extended by the latest qualifying federal-court complaint alleging an order violation; complaints, dismissal/appeal outcomes, and respondent-specific extensions are not fully tracked.

Cited by 0 later FTC decisions

Cites

Text (OCR of the scan at left; may contain errors)

IN THE MATTER OF IMPAX LABORATORIES, INC.

Docket No. 9373. Order, January 19, 2018 Order staying proceedings and extending deadlines in the event of a lapse in appropriations.

ORDER REGARDING SCHEDULING In the event that a lapse in appropriations results in a shutdown of most Commission operations, the Commission hereby directs that this proceeding be fully stayed for the duration of the shutdown and for an additional five business days thereafter. Any post-hearing deadlines will be extended by the number of calendar days of the stay. Accordingly, IT IS SO ORDERED.

By the Commission.

VOLUME 165 Interlocutory Orders, Etc.

← 165 F.T.C. 1406 · 165 F.T.C. 1408 →